These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
936 related items for PubMed ID: 28186678
1. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells. Barat S, Chen X, Cuong Bui K, Bozko P, Götze J, Christgen M, Krech T, Malek NP, Plentz RR. Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678 [Abstract] [Full Text] [Related]
2. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties. Aoki S, Mizuma M, Takahashi Y, Haji Y, Okada R, Abe T, Karasawa H, Tamai K, Okada T, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Katayose Y, Unno M. BMC Cancer; 2016 Nov 07; 16(1):854. PubMed ID: 27821106 [Abstract] [Full Text] [Related]
3. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Cai C, Zhu X. Mol Med Rep; 2012 May 07; 5(5):1191-6. PubMed ID: 22367735 [Abstract] [Full Text] [Related]
4. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z. Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949 [Abstract] [Full Text] [Related]
5. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX. Palagani V, El Khatib M, Kossatz U, Bozko P, Müller MR, Manns MP, Krech T, Malek NP, Plentz RR. PLoS One; 2012 Feb 21; 7(10):e46514. PubMed ID: 23094026 [Abstract] [Full Text] [Related]
6. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling. Chen F, Chen X, Ren Y, Weng G, Keng PC, Chen Y, Lee SO. J Mol Med (Berl); 2019 Aug 21; 97(8):1169-1182. PubMed ID: 31187175 [Abstract] [Full Text] [Related]
7. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. Abel EV, Kim EJ, Wu J, Hynes M, Bednar F, Proctor E, Wang L, Dziubinski ML, Simeone DM. PLoS One; 2014 Aug 21; 9(3):e91983. PubMed ID: 24647545 [Abstract] [Full Text] [Related]
8. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells. Yan B, Liu L, Zhao Y, Xiu LJ, Sun DZ, Liu X, Lu Y, Shi J, Zhang YC, Li YJ, Wang XW, Zhou YQ, Feng SH, Lv C, Wei PK, Qin ZF. World J Gastroenterol; 2014 Sep 28; 20(36):13105-18. PubMed ID: 25278704 [Abstract] [Full Text] [Related]
9. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses. Azzam DJ, Zhao D, Sun J, Minn AJ, Ranganathan P, Drews-Elger K, Han X, Picon-Ruiz M, Gilbert CA, Wander SA, Capobianco AJ, El-Ashry D, Slingerland JM. EMBO Mol Med; 2013 Oct 28; 5(10):1502-22. PubMed ID: 23982961 [Abstract] [Full Text] [Related]
10. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer. Lee HW, Kim SJ, Choi IJ, Song J, Chun KH. Clin Exp Metastasis; 2015 Aug 28; 32(6):593-603. PubMed ID: 26134677 [Abstract] [Full Text] [Related]
11. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG. Stem Cells; 2010 Jan 28; 28(1):5-16. PubMed ID: 19904829 [Abstract] [Full Text] [Related]
12. Role of MAML1 in targeted therapy against the esophageal cancer stem cells. Moghbeli M, Mosannen Mozaffari H, Memar B, Forghanifard MM, Gholamin M, Abbaszadegan MR. J Transl Med; 2019 Apr 16; 17(1):126. PubMed ID: 30992079 [Abstract] [Full Text] [Related]
13. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Ponnurangam S, Dandawate PR, Dhar A, Tawfik OW, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G, Umar S, Weir SJ, Sugumar A, Jensen RA, Padhye SB, Balakrishnan A, Anant S, Subramaniam D. Oncotarget; 2016 Jan 19; 7(3):3217-32. PubMed ID: 26673007 [Abstract] [Full Text] [Related]
14. RETRACTED: CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. Yoon C, Park DJ, Schmidt B, Thomas NJ, Lee HJ, Kim TS, Janjigian YY, Cohen DJ, Yoon SS. Clin Cancer Res; 2014 Aug 01; 20(15):3974-88. PubMed ID: 24947926 [Abstract] [Full Text] [Related]
15. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway. Chandra Boinpelly V, Verma RK, Srivastav S, Srivastava RK, Shankar S. J Cell Mol Med; 2020 Oct 01; 24(19):11343-11354. PubMed ID: 32830433 [Abstract] [Full Text] [Related]
16. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells. Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J, Huang H, Du Q, Geller DA, Cheng B. Oncotarget; 2016 Feb 02; 7(5):5754-68. PubMed ID: 26735577 [Abstract] [Full Text] [Related]
17. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor. Huang R, Wang G, Song Y, Tang Q, You Q, Liu Z, Chen Y, Zhang Q, Li J, Muhammand S, Wang X. Mol Med Rep; 2015 Aug 02; 12(2):2417-24. PubMed ID: 25936357 [Abstract] [Full Text] [Related]
18. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway. Liu T, Hu K, Zhao Z, Chen G, Ou X, Zhang H, Zhang X, Wei X, Wang D, Cui M, Liu C. Oncotarget; 2015 Dec 08; 6(39):41638-49. PubMed ID: 26497855 [Abstract] [Full Text] [Related]
19. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling. Wang B, Liu J, Ma LN, Xiao HL, Wang YZ, Li Y, Wang Z, Fan L, Lan C, Yang M, Hu L, Wei Y, Bian XW, Chen D, Wang J. J Gastroenterol; 2013 Jul 08; 48(7):798-808. PubMed ID: 23188090 [Abstract] [Full Text] [Related]
20. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft. Martins-Neves SR, Paiva-Oliveira DI, Fontes-Ribeiro C, Bovée JVMG, Cleton-Jansen AM, Gomes CMF. Cancer Lett; 2018 Feb 01; 414():1-15. PubMed ID: 29126913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]